Brevitest Technologies is Diagnostic Equipment in United States that focus on quantifying peptides business. Founded in 2013. They cover business area such as developer, care, enzyme, immunoassay, early stage detection, disease, less than ten minute, customizable disposable cartridge, quantifying, peptide, protein, antibody, hormone, biological sample, medical researcher, painful, time-consume laboratory-base diagnostic, abnormality.
2013
( 11 years old in 2024 )
Quantifying Peptides
-
3900 Essex Lane
Suite 575
Houston, TX 77027
United States
Private
developercareenzymeimmunoassayearly stage detectiondiseaseless than ten minutecustomizable disposable cartridgequantifyingpeptideproteinantibodyhormonebiological samplemedical researcherpainful, time-consume laboratory-base diagnosticabnormality
* We use standard office opening hours in near Brevitest Technologies's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Brevitest Technologies is Diagnostic Equipment business from United States that founded in 2013 (11 years old in 2024), Brevitest Technologies business is focusing on Quantifying Peptides.
Brevitest Technologies headquarter office and corporate office address is located in 3900 Essex Lane Suite 575 Houston, TX 77027 United States.
Brevitest Technologies was founded in United States.
In 2024, Brevitest Technologies is currently focus on quantifying peptides sector.
Above is snippet of Google Trends for "quantifying peptides" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Brevitest Technologies, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
